Ironwood Pharmaceuticals Inc
NASDAQ:IRWD
Decide at what price you'd be comfortable buying and we'll help you stay ready.
|
Ironwood Pharmaceuticals Inc
NASDAQ:IRWD
|
US |
|
U
|
US Student Housing REIT
ASX:USQ
|
AU |
|
WhiteHawk Ltd
ASX:WHK
|
AU |
|
Flame Acquisition Corp
NYSE:SOC
|
US |
|
DiaSorin SpA
OTC:DSRLF
|
IT |
|
S
|
Saudi Aramco Base Oil Company JSC
SAU:2223
|
SA |
|
Lawson Inc
TSE:2651
|
JP |
|
Bridgepoint Group PLC
LSE:BPT
|
UK |
|
Huddled Group PLC
LSE:HUD
|
UK |
|
F
|
Franklin Street Properties Corp
AMEX:FSP
|
US |
|
Sunopta Inc
F:ZSK
|
US |
|
Z
|
ZAZZ Energy of Sweden AB (publ)
F:X92
|
SE |
|
E
|
Eng Kah Corporation Bhd
KLSE:ENGKAH
|
MY |
Bankruptcy Probability
Ironwood Pharmaceuticals Inc's probability of bankruptcy is hidden . The solvency score is hidden .
We take all the information about a company's solvency (such as how easily a company can pay interest on its outstanding debt, how much cash it has, the amount of debt, and more) and use it to estimate the probability of bankruptcy.
Solvency Ratios
Solvency Ratios Comparison
Ironwood Pharmaceuticals Inc Competitors
| Country | Company | Market Cap | D/E | D/A |
Interest Coverage |
Altman Z-Score |
Quick Ratio |
Current Ratio |
Cash Ratio |
||
|---|---|---|---|---|---|---|---|---|---|---|---|
| US |
|
Ironwood Pharmaceuticals Inc
NASDAQ:IRWD
|
635.9m USD |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| FR |
|
Pharnext SCA
OTC:PNEXF
|
6T USD |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| US |
|
Abbvie Inc
NYSE:ABBV
|
380.1B USD |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| US |
|
Exact Sciences Corp
NASDAQ:EXAS
|
362.4B USD |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| US |
|
Amgen Inc
NASDAQ:AMGN
|
190.4B USD |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| US |
|
Gilead Sciences Inc
NASDAQ:GILD
|
174.1B USD |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| US |
|
Vertex Pharmaceuticals Inc
NASDAQ:VRTX
|
113.6B USD |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| US |
E
|
Epizyme Inc
F:EPE
|
94.1B EUR |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| US |
|
Regeneron Pharmaceuticals Inc
NASDAQ:REGN
|
82.2B USD |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| AU |
|
CSL Ltd
ASX:CSL
|
68.5B AUD |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| US |
S
|
Seagen Inc
F:SGT
|
39.3B EUR |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Ironwood Pharmaceuticals Inc's probability of bankruptcy is hidden .
The probability of bankruptcy is estimated using credit risk models that assess its financial health, debt levels, interest coverage, and other solvency indicators.
As of the latest report, Ironwood Pharmaceuticals Inc has total debt of 385m USD. This includes both short-term (0 USD) and long-term (385m USD) debt.
You can find a full breakdown on its Balance Sheet.
